197 related articles for article (PubMed ID: 30721686)
1. The Lens Opacities Classification System III Grading in Irradiated Uveal Melanomas to Characterize Proton Therapy-Induced Cataracts.
Mathis T; Rosier L; Meniai F; Baillif S; Maschi C; Herault J; Caujolle JP; Kodjikian L; Salleron J; Thariat J
Am J Ophthalmol; 2019 May; 201():63-71. PubMed ID: 30721686
[TBL] [Abstract][Full Text] [Related]
2. Cataract Avoidance With Proton Therapy in Ocular Melanomas.
Thariat J; Jacob S; Caujolle JP; Maschi C; Baillif S; Angellier G; Mathis T; Rosier L; Carnicer A; Hérault J; Salleron J
Invest Ophthalmol Vis Sci; 2017 Oct; 58(12):5378-5386. PubMed ID: 29049739
[TBL] [Abstract][Full Text] [Related]
3. Lens changes after proton beam irradiation for uveal melanoma.
Gragoudas ES; Egan KM; Walsh SM; Regan S; Munzenrider JE; Taratuta V
Am J Ophthalmol; 1995 Feb; 119(2):157-64. PubMed ID: 7832221
[TBL] [Abstract][Full Text] [Related]
4. Cataract development in patients treated with proton beam therapy for uveal melanoma.
Seibel I; Cordini D; Hager A; Riechardt AI; Rehak M; Böker A; Böhmer D; Heufelder J; Joussen AM
Graefes Arch Clin Exp Ophthalmol; 2016 Aug; 254(8):1625-1630. PubMed ID: 27116211
[TBL] [Abstract][Full Text] [Related]
5. Anterior segment complications after helium ion radiation therapy for uveal melanoma. Radiation cataract.
Meecham WJ; Char DH; Kroll S; Castro JR; Blakely EA
Arch Ophthalmol; 1994 Feb; 112(2):197-203. PubMed ID: 8311772
[TBL] [Abstract][Full Text] [Related]
6. Plaque radiation therapy for malignant melanoma of the iris and ciliary body.
Finger PT
Am J Ophthalmol; 2001 Sep; 132(3):328-35. PubMed ID: 11530044
[TBL] [Abstract][Full Text] [Related]
7. Corneal Substructure Dosimetry Predicts Corneal Toxicity in Patients With Uveal Melanoma Treated With Proton Beam Therapy.
Lee HJ; Stacey A; Klesert TR; Wells C; Skalet AH; Bloch C; Fung A; Bowen SR; Wong TP; Shibata D; Halasz LM; Rengan R
Int J Radiat Oncol Biol Phys; 2019 Jun; 104(2):374-382. PubMed ID: 30763658
[TBL] [Abstract][Full Text] [Related]
8. Effect of radiation dose on ocular complications after iodine brachytherapy for large uveal melanoma: empirical data and simulation of collimating plaques.
Puusaari I; Heikkonen J; Kivelä T
Invest Ophthalmol Vis Sci; 2004 Oct; 45(10):3425-34. PubMed ID: 15452045
[TBL] [Abstract][Full Text] [Related]
9. Clinical importance of the lens opacities classification system III (LOCS III) in phacoemulsification.
Bencić G; Zorić-Geber M; Sarić D; Corak M; Mandić Z
Coll Antropol; 2005; 29 Suppl 1():91-4. PubMed ID: 16193685
[TBL] [Abstract][Full Text] [Related]
10. Risk factors for neovascular glaucoma after proton beam therapy of uveal melanoma: a detailed analysis of tumor and dose-volume parameters.
Mishra KK; Daftari IK; Weinberg V; Cole T; Quivey JM; Castro JR; Phillips TL; Char DH
Int J Radiat Oncol Biol Phys; 2013 Oct; 87(2):330-6. PubMed ID: 23886415
[TBL] [Abstract][Full Text] [Related]
11. LOCS III versus the Oxford Clinical Cataract Classification and Grading System for the assessment of nuclear, cortical and posterior subcapsular cataract.
Hall AB; Thompson JR; Deane JS; Rosenthal AR
Ophthalmic Epidemiol; 1997 Dec; 4(4):179-94. PubMed ID: 9500153
[TBL] [Abstract][Full Text] [Related]
12. Correlation among lens opacities classification system III grading, visual function index-14, pentacam nucleus staging, and objective scatter index for cataract assessment.
Pan AP; Wang QM; Huang F; Huang JH; Bao FJ; Yu AY
Am J Ophthalmol; 2015 Feb; 159(2):241-7.e2. PubMed ID: 25448993
[TBL] [Abstract][Full Text] [Related]
13. The Lens Opacities Classification System III. The Longitudinal Study of Cataract Study Group.
Chylack LT; Wolfe JK; Singer DM; Leske MC; Bullimore MA; Bailey IL; Friend J; McCarthy D; Wu SY
Arch Ophthalmol; 1993 Jun; 111(6):831-6. PubMed ID: 8512486
[TBL] [Abstract][Full Text] [Related]
14. Ruthenium brachytherapy for uveal melanomas: Factors affecting the development of radiation complications.
Pagliara MM; Tagliaferri L; Azario L; Lenkowicz J; Lanza A; Autorino R; Caputo CG; Gambacorta MA; Valentini V; Blasi MA
Brachytherapy; 2018; 17(2):432-438. PubMed ID: 29275868
[TBL] [Abstract][Full Text] [Related]
15. Cataractogenesis after Cobalt-60 eye plaque radiotherapy.
Kleineidam M; Augsburger JJ; Hernandez C; Glennon P; Brady LW
Int J Radiat Oncol Biol Phys; 1993 Jul; 26(4):625-30. PubMed ID: 8330992
[TBL] [Abstract][Full Text] [Related]
16. Helium-ion-induced human cataractogenesis.
Blakely EA; Daftari IK; Meecham WJ; Alonso LC; Collier JM; Kroll SM; Gillette EL; Lee AC; Lett JT; Cox AB; Castro JR; Char DH
Adv Space Res; 1994 Oct; 14(10):501-5. PubMed ID: 11539986
[TBL] [Abstract][Full Text] [Related]
17. Comparative analysis of the nuclear lens opalescence by the Lens Opacities Classification System III with nuclear density values provided by Oculus Pentacam: a cross-section study using Pentacam Nucleus Staging software.
Magalhães FP; Costa EF; Cariello AJ; Rodrigues EB; Hofling-Lima AL
Arq Bras Oftalmol; 2011; 74(2):110-3. PubMed ID: 21779666
[TBL] [Abstract][Full Text] [Related]
18. Grading nuclear, cortical and posterior subcapsular cataracts using an objective scatter index measured with a double-pass system.
Vilaseca M; Romero MJ; Arjona M; Luque SO; Ondategui JC; Salvador A; Güell JL; Artal P; Pujol J
Br J Ophthalmol; 2012 Sep; 96(9):1204-10. PubMed ID: 22790434
[TBL] [Abstract][Full Text] [Related]
19. Lack of radiation maculopathy after palladium-103 plaque radiotherapy for iris melanoma.
Yousef YA; Finger PT
Int J Radiat Oncol Biol Phys; 2012 Jul; 83(4):1107-12. PubMed ID: 22172910
[TBL] [Abstract][Full Text] [Related]
20. Lens autofluorescence and light scatter in relation to the lens opacities classification system, LOCS III.
Siik S; Chylack LT; Friend J; Wolfe J; Teikari J; Nieminen H; Airaksinen PJ
Acta Ophthalmol Scand; 1999 Oct; 77(5):509-14. PubMed ID: 10551289
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
